Evolent Health, Inc. (EVH)
3.53
+0.07
(+2.02%)
USD |
NYSE |
Oct 05, 12:41
Evolent Health Enterprise Value : 1.222B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.222B |
| October 01, 2026 | 1.214B |
| September 30, 2026 | 1.225B |
| September 29, 2026 | 1.228B |
| September 28, 2026 | 1.243B |
| September 25, 2026 | 1.239B |
| September 24, 2026 | 1.228B |
| September 23, 2026 | 1.240B |
| September 22, 2026 | 1.260B |
| September 21, 2026 | 1.248B |
| September 18, 2026 | 1.248B |
| September 17, 2026 | 1.245B |
| September 16, 2026 | 1.253B |
| September 15, 2026 | 1.253B |
| September 14, 2026 | 1.294B |
| September 11, 2026 | 1.304B |
| September 10, 2026 | 1.302B |
| September 09, 2026 | 1.299B |
| September 08, 2026 | 1.307B |
| September 04, 2026 | 1.319B |
| September 03, 2026 | 1.312B |
| September 02, 2026 | 1.308B |
| September 01, 2026 | 1.314B |
| August 31, 2026 | 1.339B |
| August 28, 2026 | 1.350B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.349B |
| August 26, 2026 | 1.386B |
| August 25, 2026 | 1.383B |
| August 24, 2026 | 1.364B |
| August 21, 2026 | 1.366B |
| August 20, 2026 | 1.361B |
| August 19, 2026 | 1.348B |
| August 18, 2026 | 1.348B |
| August 17, 2026 | 1.329B |
| August 14, 2026 | 1.359B |
| August 13, 2026 | 1.357B |
| August 12, 2026 | 1.302B |
| August 11, 2026 | 1.294B |
| August 10, 2026 | 1.275B |
| August 07, 2026 | 1.277B |
| August 06, 2026 | 1.236B |
| August 05, 2026 | 1.179B |
| August 04, 2026 | 1.182B |
| August 03, 2026 | 1.186B |
| July 31, 2026 | 1.180B |
| July 30, 2026 | 1.190B |
| July 29, 2026 | 1.204B |
| July 28, 2026 | 1.253B |
| July 27, 2026 | 1.261B |
| July 24, 2026 | 1.307B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DarioHealth Corp. | 65.59M |
| CompuMed, Inc. | 6.951M |
| Teladoc Health, Inc. | 1.265B |
| Renalytix Plc | -- |
| Lifestance Health Group, Inc. | 4.768B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -28.36M |
| Revenue (Quarterly) | 652.52M |
| Total Expenses (Quarterly) | 680.88M |
| EPS Diluted (Quarterly) | -0.252 |
| Gross Profit Margin (Quarterly) | 9.08% |
| Profit Margin (Quarterly) | -4.35% |
| Earnings Yield | -129.5% |
| Normalized Earnings Yield | -54.03 |